Business

3D bioprinting – printing cranial plugs, hearts, lungs, limbs … could we be printing drugs?

Maruthappu, M. and B. Keogh (2014). How might 3D printing affect clinical practice? BMJ 2014;349:g7709 http://www.bmj.com/content/349/bmj.g7709

Changing clinical practice and business models:

“When added to the ever increasing availability of printers,… The internet is no longer simply an information vehicle but a delivery vehicle, decentralising and accelerating the manufacturing process.”

“…combined with medical imaging, 3D printing also has the potential to revolutionise […]

On the rise of the “translational state” – The State commitment to accelerating the commercial translation of biomedical research

Hogarth, S. “Neoliberal technocracy: Explaining how and why the US Food and Drug Administration has championed pharmacogenomics.” Social Science & Medicine. Available online 15 January 2015 – In Press, Accepted Manuscript
http://www.sciencedirect.com/science/article/pii/S0277953615000313

Abstract:
“By 2004 the FDA had emerged as a champion of pharmacogenomics as an exemplar for novel approaches to drug development. This was made clear in 2004 when […]

The Farr Institute of Health Informatics and the ABPI Industry Forum

This conference was organised by The Farr Institute of Health Informatics Research in conjunction with The Association of the British Pharmaceutical Industry and the UK Health Informatics Research Network and was held on Tuesday 16th December 2014 at the Royal College of General Practitioners, 30 Euston Square in London. It was booked out, with just over 130 attendees from […]

McKinsey report: A digital prescription for pharma companies

Patients are changing, Governments are moving… “Pharmaceutical and medical-device companies have been slow to adopt digitization. Here are five reasons they should get moving…”

for digitally enabled healthcare…

 

The report is here: http://www.mckinsey.com/insights/health_systems_and_services/a_digital_prescription_for_pharma_companies

 

December 6th, 2014|Business, Medicine|0 Comments|

Ten digital pharma failures

A blog post by Dom Marchant & Matt Lowe, on how “digital is no longer a bolt-on, but the predominant channel within pharma”, and ten things not to do in the business..

Read more at: http://www.pharmatimes.com/magazine/blogdetails.aspx?id=0ebffbc3-bed0-4c9b-b260-642dfec06c85#.Uwtko8umGU8.email#ixzz3L8Czz4sC

February 24th, 2014|Business|0 Comments|